Get started
AMGEN INC CEDEAR EACH 30 REP 1AMGEN INC CEDEAR EACH 30 REP 1AMGEN INC CEDEAR EACH 30 REP 1

AMGEN INC CEDEAR EACH 30 REP 1

No trades
See on Supercharts
Overview
News Ideas Technicals

AMGN chart

Key stats

Market capitalization
‪127.92 T‬ARS
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
Net income
—
Revenue
—
Shares float
—
Beta (1Y)
0.53

About AMGEN INC CEDEAR EACH 30 REP 1

Sector
Health Technology
CEO
Robert A. Bradway
Headquarters
Thousand Oaks
Website
amgen.com
Founded
1980
ISIN
ARDEUT110665
FIGI
BBG000HDQXN6
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Sparks

Curated watchlists where AMGN is featured.

See all sparks